Paul A. Kyrle

17.7k citations

209 papers · 11.8k indexed · 4 hit papers · h-index 52

Hematology top 0.05%
Internal Medicine top 0.02%
Cardiology and Cardiovascular Medicine top 0.5%
Surgery top 1%
Immunology top 1%

Co-authors: Sabine Eichinger Klaus Lechner Ansgar Weltermann Mirko Hirschl Thomas Thiele Theodore E. Warkentin Andreas Greinacher Karin Weißer
Topics: Venous Thromboembolism Diagnosis and Management (118 papers)Blood Coagulation and Thrombosis Mechanisms (94 papers)Atrial Fibrillation Management and Outcomes (62 papers)
Cited by: Internal Medicine Hematology Cardiology and Cardiovascular Medicine
Journals: New England Journal of Medicine Proceedings of the National Academy of Sciences The Lancet
Partner nations: Austria United States Germany

In The Last Decade

Paul A. Kyrle

201 papers receiving 11.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

2021 1.4k citations Paul A. Kyrle, Sabine Eichinger et al. profile →
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome

1998 1.3k citations Paul A. Kyrle et al. profile →
High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism

2000 568 citations Paul A. Kyrle, Mirko Hirschl et al. profile →
Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH

2016 401 citations Suzanne C. Cannegieter, Paul A. Kyrle et al. Journal of Thrombosis and Haemostasis profile →

Peers

Countries citing papers authored by Paul A. Kyrle

Since Specialization

Citations

This map shows the geographic impact of Paul A. Kyrle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul A. Kyrle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul A. Kyrle more than expected).

Fields of papers citing papers by Paul A. Kyrle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul A. Kyrle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul A. Kyrle. The network helps show where Paul A. Kyrle may publish in the future.

Co-authorship network of co-authors of Paul A. Kyrle

This figure shows the co-authorship network connecting the top 25 collaborators of Paul A. Kyrle. A scholar is included among the top collaborators of Paul A. Kyrle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul A. Kyrle. Paul A. Kyrle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Towards a tailored diagnostic standard for future diagnostic studies in pulmonary embolism: communication from the SSC of the ISTH 2017 ·Journal of Thrombosis and Haemostasis ·C.E.A. Dronkers,Tom van der Hulle,Grégoire Le Gal,Paul A. Kyrle,Menno V. Huisman,Suzanne C. Cannegieter,Frederikus A. Klok	79
2	Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data 2015 ·Journal of Thrombosis and Haemostasis ·Maura Marcucci,Alfonso Iorio,James D. Douketis,Sabine Eichinger,Alberto Tosetto,Trevor Baglin,Mary Cushman,Gualtiero Palareti,Daniela Poli,Robert C. Tait,Paul A. Kyrle	43
3	Sex difference in the risk of recurrent venous thrombosis: a detailed analysis in four European cohorts 2015 ·Journal of Thrombosis and Haemostasis ·R.E.J. Roach,Willem M. Lijfering,Robert C. Tait,Trevor Baglin,Paul A. Kyrle,Suzanne C. Cannegieter,Frits R. Rosendaal	21
4	The risk of recurrence in women with venous thromboembolism while using estrogens: a prospective cohort study 2014 ·Journal of Thrombosis and Haemostasis ·Lisbeth Eischer,Sabine Eichinger,Paul A. Kyrle	39
5	Low dose acetylsalicylic acid and shedding of microparticles in vivo in humans 2010 ·European Journal of Clinical Investigation ·(unknown),Marietta Kollars,Gregor Hron,Paul A. Kyrle,Ansgar Weltermann,(unknown)	27
6	Age at First Venous Thromboembolism and Risk of Recurrence 2009 ·Medicine ·Lisbeth Eischer,Sabine Eichinger,Paul A. Kyrle	37
7	Genetic variation in heme oxygenase 1 (HMOX1) and the risk of recurrent venous thromboembolism 2008 ·Journal of Vascular Surgery ·Stefan Mustafa,Ansgar Weltermann,(unknown),Claudia Marsik,Oswald Wagner,Paul A. Kyrle,Sabine Eichinger	35
8	Low vitamin B6 levels and the risk of recurrent venous thromboembolism 2007 ·Haematologica ·Gregor Hron,Rosa Lombardi,Sabine Eichinger,Anna Lecchi,Paul A. Kyrle,Marco Cattaneo	24
9	Prediction of recurrent venous thromboembolism by the activated partial thromboplastin time 2006 ·Journal of Thrombosis and Haemostasis ·Gregor Hron,Sabine Eichinger,A. Weltermann,Peter Quehenberger,(unknown),Paul A. Kyrle	53
10	Risk of pregnancy‐associated recurrent venous thromboembolism in women with a history of venous thrombosis 2005 ·Journal of Thrombosis and Haemostasis ·Ingrid Pabinger,Helga Grafenhofer,Alexandra Kaider,Paul A. Kyrle,Peter Quehenberger,Christine Mannhalter,Klaus Lechner	155
11	The risk of recurrent venous thromboembolism in men and women 2004 ·Journal of Vascular Surgery ·Paul A. Kyrle,E Minar,Christine Bialonczyk	1
12	High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension 2003 ·Thrombosis and Haemostasis ·Diana Bonderman,Peter L. Turecek,Johannes Jakowitsch,Ansgar Weltermann,Christopher Adlbrecht,Barbara Schneider,Meinhard Kneußl,Lewis J. Rubin,Paul A. Kyrle,Walter Klepetko,Gerald Maurer,Iréne Lang	161
13	The risk of recurrent venous thromboembolism among patients with high factor IX levels 2003 ·Journal of Thrombosis and Haemostasis ·A. Weltermann,Sabine Eichinger,Christine Bialonczyk,E Minar,Mirko Hirschl,Peter Quehenberger,Verena Schönauer,Paul A. Kyrle	70
14	Clonal T cell‐mediated cyclic thrombocytopenia 2002 ·British Journal of Haematology ·Wolfgang Füreder,Gerlinde Mitterbauer,Renate Thalhammer,Klaus Geißler,Simon Panzer,Michael Krebs,(unknown),Wolfgang R. Sperr,Klaus Lechner,Paul A. Kyrle	15
15	The Factor V (Leiden) Test 1999 ·Thrombosis Research ·Peter Quehenberger,Sylvia Handler,Christine Mannhalter,Paul A. Kyrle,Wolfgang Speiser	18
16	No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylenetetrahydrofolate-reductase gene 1999 ·Blood Coagulation & Fibrinolysis ·C. Rintelen,Christine Mannhalter,Klaus Lechner,Sabine Eichinger,Paul A. Kyrle,Menelaos Papagiannopoulos,Barbara Schneider,Ingrid Pabinger	25
17	Transient lupus anticoagulant associated with hypoprothrombinemia and Factor XII deficiency following adenovirus infection 1993 ·Annals of Hematology ·Ulrich Jaeger,S. Kapiotis,Ingrid Pabinger,Elisabeth Puchhammer,Paul A. Kyrle,Klaus Lechner	54
18	Absence of interaction between tenoxicam and warfarin 1992 ·European Journal of Clinical Pharmacology ·H G Eichler,Martin Jung,Paul A. Kyrle,(unknown),A. Korn	6
19	Hepatic and splenic abscesses — a common complication of intensive chemotherapy of acute myeloid leukemia (AML) 1991 ·Annals of Hematology ·Nicole Grois,G. Mostbeck,R. Scherrer,Andreas Chott,Ilse Schwarzinger,Manfred Muhm,Peter Bettelheim,(unknown),Klaus Laczika,Paul A. Kyrle,Klaus Lechner	14
20	Decreased Serum Osteocalcin Levels in Phenprocoumon-Treated Patients 1988 ·The Journal of Clinical Endocrinology & Metabolism ·Peter Pietschmann,W. Woloszczuk,Simon Panzer,Paul A. Kyrle,J. S. Smolen	45

About Paul A. Kyrle

Paul A. Kyrle is a scholar working on Internal Medicine, Hematology and Cardiology and Cardiovascular Medicine, having authored 209 papers that have together received 11.8k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (118 papers), Blood Coagulation and Thrombosis Mechanisms (94 papers) and Atrial Fibrillation Management and Outcomes (62 papers). The work is most often cited by research in Internal Medicine (5.8k citations), Hematology (6.2k citations) and Cardiology and Cardiovascular Medicine (3.9k citations). Paul A. Kyrle has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Sabine Eichinger, Klaus Lechner, Ansgar Weltermann, Mirko Hirschl, Thomas Thiele, Theodore E. Warkentin, Andreas Greinacher, Karin Weißer, Ingrid Pabinger and Christine Bialonczyk. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact